Medical Nutrition Advisor (Board Advisory Role)
Summary
An experienced Medical Nutrition specialist is sought to provide strategic advisory support for an oral metabolic therapy addressing chronic leg-ulcer healing, guiding nutritional claims, clinical-evidence development, NHS market-entry, and consumer OTC strategies.
This mandate initially involves low-commitment advisory work, approximately two days per month. Depending on your situation and interests, the role could evolve into a fractional or full-time Medical Nutrition Director position as the business scales. Alternatively, you'd be instrumental in identifying and onboarding a long-term hire, depending on your preference / availability.
The business
The company is completing a 20-patient UK pilot; within 12 weeks, results are expected to support a £0.25–1 million SEIS/EIS raise, followed by a 200-patient pivotal study and a further £2 million+ round for borderline-medicine approval. Current market offerings from large multinational consumer-health businesses are oral wound-support products that lack clinical evidence, precluding NHS prescription. This company aims to offer the first clinically proven, reimbursable oral solution, supported by robust UK clinical trials and a comprehensive IP strategy.
Trials are conducted by Pioneer Wound Care, the UK's largest provider, ensuring high-quality data meeting regulatory standards. Success is anticipated due to robust third-party in vitro studies demonstrating significant collagen type II increases, with the upcoming trials specifically targeting wound-relevant collagen types I and III.
Three sequential patents are planned over approximately three years:
- Single pathway, single compound (current application)
- Single pathway, multiple compounds
- Multiple pathways, multiple compounds
Key people
- Founder CEO: Experienced entrepreneur in longevity-nutrition ventures, biochemistry background, self-funded early-stage IP and clinical planning.
- Chair: Serial bio-entrepreneur (Founder/CSO) successfully commercialising a marine-collagen healthcare product currently undergoing FDA approval; strong expertise in skin-related clinical trials and entrepreneurial leadership.
- Board Advisor (Clinical Trials): Clinical Trials Lead at Pioneer Wound Care; practising tissue-viability specialist overseeing trial design and execution, ensuring alignment with MHRA and NICE standards.
- Board Advisor (Pharmacy & Population Health): NHS ICB Trust lead, expert in pharmacy strategy and population health management.
Value-add
Your primary contribution will involve minimising execution risk through clinical trial strategy refinement, regulatory claim positioning (borderline medicine and FSMP), NHS market-entry preparation, and consumer OTC strategic direction. Existing strategic scientific advice is available from the Chair (experienced CSO within wound-care / collagen-based treatment), though this is a transitional solution due to other business commitments and a full time CSO will be brought in. They will act in an advisory capacity in the near term.
Candidates may come from either:
- Commercial Nutrition Background: Strategic or commercial roles within leading medical nutrition or consumer-health businesses (e.g. Abbott Nutrition, Danone Nutricia, Nestlé Health Science), experienced in product launches, evidence-based claims, and regulatory navigation.
- Clinical/Pharmacy Leadership Background: Senior roles in nutritional medicine or applied pharmacy, experienced in clinical trials, regulatory frameworks, and strategic clinical development.
Essential qualifications:
- Degree in human medicine, pharmacy, applied biochemistry, biotechnology, or related field.
- Successfully completed management qualification, ideally an MBA.
- Minimum of five years' experience in nutritional medicine, clinical nutrition, or pharmacy.
- Demonstrated expertise in clinical trials and application studies.
Compensation
Compensation is primarily growth-share-based, supplemented by cash following the patent grant, positive pilot-study results, and initial SEIS tranche completion; precise terms to be agreed.
Process
Initial informal call with the founder to explore mutual fit, followed by targeted discussions with the Chair and clinical team prior to formal offer.